Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses
Not Applicable
Completed
- Conditions
- Asthma Patients
- Interventions
- Drug: XKH001 Injection
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Zhejiang Kanova Biopharmaceutical Co., LTD
- Target Recruit Count
- 12
- Registration Number
- NCT07070297
- Locations
- 🇨🇳
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis
Not Applicable
Not yet recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: XKH001 InjectionDrug: XKH001 Placebo Injection
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Zhejiang Kanova Biopharmaceutical Co., LTD
- Target Recruit Count
- 120
- Registration Number
- NCT07054736
- Locations
- 🇨🇳
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Phase I of XKH002 Injection in Patients
Phase 1
Recruiting
- Conditions
- Advanced or Metastatic Solid Tumors
- Interventions
- Drug: XKH002 Injection
- First Posted Date
- 2024-01-09
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Zhejiang Kanova Biopharmaceutical Co., LTD
- Target Recruit Count
- 110
- Registration Number
- NCT06196762
- Locations
- 🇨🇳
Peking University Cancer Hospital, Beijing, China
News
No news found